DHAP regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Overview
Overview
DHAP regimen refers to a chemotherapy regimen consisting of dexamethasone, high-dose cytarabine (Ara-C) and cisplatin, used to treat relapsed and refractory non-Hodgkin’s and Hodgkin’s lymphoma.[1]
Regimen
Regimen
DDexamethasone
HHigh Dose
ACytarabine (Ara-C)
PCisplatin
References
References
- ↑ 1.0 1.1 Velasquez WS, Cabanillas F, Salvador P, McLaughlin P, Fridrik M, Tucker S; et al. (1988). “Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)”. Blood. 71 (1): 117–22. PMID 3334893.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH